Nadim Ahmed
President and CEO at Cullinan Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Cullinan Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cullinan Therapeutics Inc. June 16, 202675.6%
-
Cullinan Therapeutics Inc. June 8, 202398.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Cullinan Therapeutics Inc. | Open-market sale | −13,515 | $14.47 | $195,562 |
| Feb 20, 2026 | Cullinan Therapeutics Inc. | Open-market sale | −16,381 | $13.62 | $223,109 |
| Dec 23, 2025 | Cullinan Therapeutics Inc. | Open-market sale | −9,922 | $10.01 | $99,319 |
| Feb 25, 2025 | Cullinan Therapeutics Inc. | Open-market sale | −12,529 | $8.53 | $106,872 |
| Feb 19, 2025 | Cullinan Therapeutics Inc. | Grant or award | +180,000 | — | — |
| Dec 24, 2024 | Cullinan Therapeutics Inc. | Open-market sale | −8,400 | $11.87 | $99,708 |
| Feb 22, 2024 | Cullinan Therapeutics Inc. | Grant or award | +160,000 | — | — |
| Dec 26, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −4,272 | $9.24 | $39,473 |
| Jun 28, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −759 | $11.40 | $8,653 |
| May 23, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −707 | $9.15 | $6,469 |
| Apr 25, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −716 | $10.59 | $7,582 |
| Mar 23, 2023 | Cullinan Therapeutics Inc. | Open-market sale | −706 | $10.51 | $7,420 |
| Feb 22, 2023 | Cullinan Therapeutics Inc. | Grant or award | +109,000 | — | — |
Questions about Nadim Ahmed
What boards is Nadim Ahmed on?
Nadim Ahmed sits on the boards of Cullinan Therapeutics Inc. and Disc Medicine Inc.
What company is Nadim Ahmed the CEO of?
Nadim Ahmed is President and CEO of Cullinan Therapeutics Inc.
How long has Nadim Ahmed served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.